The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Green, A. Richard, Mechan, Annis O., Elliott, J. Martin, O’Shea, Esther, Colado, M. Isabel·2003·Pharmacological Reviews
DOI 10.1124/pr.55.3.3

Cites (435)

Items 401–436 of 436

  1. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation
    Yukihiko Shirayama, Kenji Hashimoto, Masaomi Iyo, Keiichiro Watanabe, Teruhiko Higuchi, Yoshio Minabe · 2000 · European Journal of Pharmacology
  2. Effects of Smoking and Smoking Deprivation on the Articulatory Loop of Working Memory
    Jonathan J. Blake, Andrew Paul Smith · 1997 · Human Psychopharmacology Clinical and Experimental
  3. The Effect of the Repeated Administration of the Compound 3,4-Methylenedioxymethamphetamineon the Response of Rats to the5-HT2A,C Receptor Agonist (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)
    Martin I. Granoff, C. R. Ashby · 1997 · Neuropsychobiology
  4. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats
    S.Y. Yeh, Fu‐Lian Hsu · 1991 · Pharmacology Biochemistry and Behavior
  5. Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo.
    Sarah E. Gartside, Richard McQuade, T Sharp · 1996 · Journal of Pharmacology and Experimental Therapeutics
  6. Does GFAP mRNA and mitochondrial benzodiazepine receptor binding detect serotonergic neuronal degeneration in rat?
    Caterina Bendotti, Sonia Baldessari, Mario Pende, Gianluca Tarizzo, Anna Miari, Maria Laura Presti, Tiziana Mennini, ROSARIO SAMANIN · 1994 · Brain Research Bulletin
  7. Methylenedioxyamphetamine: neurotoxic effects on serotonergic projections to brainstem nuclei in the rat
    John A. Harvey, Scott E. McMaster, Anthony G. Romano · 1993 · Brain Research
  8. Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin
    Tanja Obradovic, Kevin M. Imel, Susan R White · 1998 · Brain Research
  9. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Richard E. Heikkila, Felicitas S. Cabbat, Lawrence Manzino, Ronald G. Babington, William J. Houlihan · 1981 · Journal of Pharmacology and Experimental Therapeutics
  10. Ecstasy and neurodegeneration: Advice is that “less is more”
    John Merrill · 1996 · BMJ
  11. Intrasynaptosomal Sequestration of [3H]Amphetamine and [3H]Methylenedioxyamphetamine: Characterization Suggests the Presence of a Factor Responsible for Maintaining Sequestration
    Robert C. Zaczek, Steven G. Culp, Errol B. De Souza · 1990 · Journal of Neurochemistry
  12. Protection against 3,4‐methylenedioxymethamphetamine‐induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia
    Esther O’Shea, Neil Easton, J. R. Fry, A R Green, Charles Alexander Marsden · 2002 · Journal of Neurochemistry
  13. 3,4-Methylenedioxymethamphetamine (“Ecstasy”) Stimulates the Expression of α1(I) Procollagen mRNA in Hepatic Stellate Cells
    Marta Varela‐Rey, Cristina Montiel‐Duarte, Guadalupe Beitia, Edurne Cenarruzabeitia, María J. Iraburu · 1999 · Biochemical and Biophysical Research Communications
  14. Effects of MDMA (‘ecstasy’) on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat
    Montford F. Piercey, Janet T. Lum, John R. Palmer · 1990 · Brain Research
  15. Induction of Fos protein by 3,4‐ methylenedioxymethamphetamine (Ecstasy) in rat brain: regional differences in pharmacological manipulation
    Kenji Hashimoto, Shinichiro Tomitaka, Natsuko Narita, Yoshio Minabe, Masaomi Iyo · 1997 · Addiction Biology
  16. Amphetamine Toxicity in Aggregated Mice
    Beryl M. Askew · 1961 · Journal of Pharmacy and Pharmacology
  17. Pharmacology of the Hypothalamus
    B. Cox, Ian D. Morris, A. H. Weston · 1978 · Palgrave Macmillan UK eBooks
  18. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
    Michel Johnson, K. Mitros, Donna M. Stone, R. Howard Zobrist, Glen R. Hanson, James W. Gibb · 1992 · Journal of Pharmacology and Experimental Therapeutics
  19. Fluoxetine - induced mania in a patient with post-stroke depression
    Marcelo Luis Berthier, Jaime Kulisevsky · 1993 · The British Journal of Psychiatry
  20. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat
    Cameron R. Hekmatpanah, Dennis J. McKenna, Stephen J. Peroutka · 1989 · Neuroscience Letters
  21. Smoking and cognitive decline
    Joyce E. Whittington, Felicia A. Huppert · 1997 · Human Psychopharmacology Clinical and Experimental
  22. Tablets often contain substances in addition to, or instead of, ecstasy..
    ADAM R. WINSTOCK, Leslie A. King · 1996 · BMJ
  23. The hypothalamus and the pharmacology of thermoregulation
    Anthony S. Milton · 1978 · Palgrave Macmillan UK eBooks
  24. Effect of bupropion on chocolate craving
    Gary F. Michell, Andrew H. Mebane, CHARLES K. BILLINGS · 1989 · American Journal of Psychiatry
  25. Effects of ecstasy on aldosterone secretion in the ratin vivoandin vitro.
    N. Burns, Henry J. Olverman, P. A. T. Kelly, Brent C. Williams · 1996 · Endocrine Research
  26. Hyperthermia and the amphetamine aggregation phenomenon: Absence of a causal relation
    Harold H. Wolf, Mari E Bunce · 1973 · Journal of Pharmacy and Pharmacology
  27. The Interaction between the Central and Peripheral Nervous Systems in Mediating the Thermic Effect of Methamphetaminea
    Rymond A. Mohaghegh, Michael Soulsby, R.D. Skinner, Richard H. Kennedy · 1997 · Annals of the New York Academy of Sciences
  28. In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine
    James E. Murphy, James Flynn, Dara M. Cannon, Patrick J. Guiry, Peter McCormack, Alan W. Baird, Gethin J. McBean, ALAN K. KEENAN · 2002 · European Journal of Pharmacology
  29. Incontinence after stroke
    Tove Henriksen · 1991 · The Lancet
  30. Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and α2A/D-adrenoceptor knockout mice
    Kushwin Rajamani, Stephen Leong, Aisling Lavelle, James R. Docherty · 2001 · European Journal of Pharmacology
  31. No evidence of neurotoxicity exists
    Nicholas Andrew Saunders · 1996 · BMJ
  32. Protection by MK 801 and other drugs of methylenedioxy-methamphetamine (MDMA) neurotoxicity in rats and mice
    Richard Laverty, B.J. Logan · 1990 · European Journal of Pharmacology
  33. Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity
    S CHE, M JOHNSON, Hanson Gr, James W. Gibb · 1995 · European Journal of Pharmacology
  34. In vitro neuronal and vascular responses to 5‐HT in rats chronically exposed to MDMA
    Dara M. Cannon, ALAN K. KEENAN, Patrick J. Guiry, Christophe Buon, Alan W. Baird, Gethin J. McBean · 2001 · British Journal of Pharmacology
  35. A growing industry and menace: makeshift laboratory's designer drugs
    T. Ziporyn · 1986 · JAMA
  36. Pediatric Surgery
    Marc I. Rowe · 1987 · JAMA